Janssen

GURC | 212082PCR4049

NCT03501173

JCP048

A Study of Participants With Advanced Prostate Cancer in Canada (GURC)

Status:

Recruiting

26459-200.png

Observational

Phase

Line of Therapy.png

N/A

Line of Therapy

Disease Stage.png

Advanced / Metastatic

Disease Stage

Target.png

Biomarker(s)

N/A

Investigational

Product

Zytiga, Erleada

Treatment Arms

o Metastatic Castrate-Sensitive Prostate Cancer (mCSPC)

o Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

o NonMetastatic Castrate-Resistant Prostate Cancer (nmCRPC)